This article mentions the benefits of using non-invasive tests, such as procalcitonin (PCT), Laboratory Risk Indicator for Necrotizing Fasciitis (LRINEC) scoring, and other non-invasive serological markers of inflammation that can aid in the diagnosis of NF in its early stages for earlier treatment and better outcomes. This evidence concerns the gene CALCA and fasciitis.